Analysis of the molecular mechanisms by flavonoids with potential use for osteoporosis prevention or therapy
V Rodríguez, M Rivoira, G Picotto… - Current Medicinal …, 2022 - ingentaconnect.com
V Rodríguez, M Rivoira, G Picotto, GD de Barboza, A Collin, N Tolosa de Talamoni
Current Medicinal Chemistry, 2022•ingentaconnect.comBackground: Osteoporosis is the most common skeletal disorder worldwide. Flavonoids
have the potential to alleviate bone alterations in osteoporotic patients with the advantage of
being safer and less expensive than conventional therapies. Objective: The main objective
is to analyze the molecular mechanisms triggered in bone by different subclasses of
flavonoids. In addition, this review provides an up-to-date overview of the cellular and
molecular aspects of osteoporotic bones versus healthy bones, and a brief description of …
have the potential to alleviate bone alterations in osteoporotic patients with the advantage of
being safer and less expensive than conventional therapies. Objective: The main objective
is to analyze the molecular mechanisms triggered in bone by different subclasses of
flavonoids. In addition, this review provides an up-to-date overview of the cellular and
molecular aspects of osteoporotic bones versus healthy bones, and a brief description of …
Background
Osteoporosis is the most common skeletal disorder worldwide. Flavonoids have the potential to alleviate bone alterations in osteoporotic patients with the advantage of being safer and less expensive than conventional therapies.
Objective
The main objective is to analyze the molecular mechanisms triggered in bone by different subclasses of flavonoids. In addition, this review provides an up-to-date overview of the cellular and molecular aspects of osteoporotic bones versus healthy bones, and a brief description of some epidemiological studies indicating that flavonoids could be useful for osteoporosis treatment.
Methods
The PubMed database was searched in 2001- 2021 using the keywords osteoporosis, flavonoids, and their subclasses such as flavones, flavonols, flavanols, isoflavones, flavanones and anthocyanins, focusing the data on the molecular mechanisms triggered in bone.
Results
Although flavonoids comprise many compounds that differ in structure, their effects on bone loss in postmenopausal women or in ovariectomized-induced osteoporotic animals are quite similar. Most of them increase bone mineral density and bone strength, which occur through an enhancement of osteoblastogenesis and osteoclast apoptosis, a decrease in osteoclastogenesis, as well as an increase in neovascularization on the site of the osteoporotic fracture.
Conclusion
Several molecules of signaling pathways are involved in the effect of flavonoids on osteoporotic bone. Whether all flavonoids have a common mechanism or they act as ligands of estrogen receptors remains to be established. More clinical trials are necessary to know better their safety, efficacy, delivery and bioavailability in humans, as well as comparative studies with conventional therapies.
ingentaconnect.com
以上显示的是最相近的搜索结果。 查看全部搜索结果